Literature DB >> 16547965

Exhaled carbon monoxide levels in school-age children with episodic asthma.

Yoichiro Ohara1, Takashi Ohrui, Toshio Morikawa, Mei He, Hiroyasu Yasuda, Mutsuo Yamaya, Hidetada Sasaki.   

Abstract

Carbon monoxide (CO) can be detected in exhaled air and is increased in adult and childhood persistent asthmatic patients. However, little is known about the exhaled CO concentration in episodic childhood asthma. This study aimed to clarify whether measurement of exhaled CO is useful in monitoring disease activity in children with episodic asthma. We measured exhaled CO concentration by modified Micro-Smokerlyzer in 217 elementary school children (132 boys; mean age, 10 +/- 1 (SE) years; range, 9-12 years), in whom 29 had infrequent episodic asthma without current exacerbations. We also measured exhaled CO concentrations in 22 children with episodic asthma (13 boys; mean age, 10 +/- 3 years; range, 8-12 years), who had acute mild asthmatic attacks during examination. In these patients with mild asthmatic attacks, exhaled CO was measured both before and after combination therapy with salbutamol and sodium cromoglycate (SCG) by powered nebulizer. Among 217 schoolchildren, exhaled CO levels in infrequent episodic asthmatic children (1.1 +/- 0.1 parts per million (ppm), n = 29) were not significantly different from those in healthy schoolchildren (1.0 +/- 0.1 ppm, n = 188, P > 0.68). The exhaled CO concentrations during asthma attacks in children with episodic asthma were significantly higher (5.1 +/- 0.4 ppm, n = 22) compared with those in healthy children (P < 0.001) or those in asymptomatic asthmatic children (P < 0.001). The elevated exhaled CO levels were significantly decreased after inhalation therapy of a combination of salbutamol and SCG (3.2 +/- 0.5 ppm, n = 22, P < 0.02). In conclusion, exhaled CO levels were significantly elevated during acute asthma exacerbations, and partially recovered after treatment with beta(2)-agonist and SCG in children with mild episodic asthma. These findings indicate that measurement of exhaled CO might provide another noninvasive measurement of asthma exacerbations that would be suitable for use in children with acute mild episodic asthma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16547965     DOI: 10.1002/ppul.20395

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  5 in total

Review 1.  Exhaled carbon monoxide in asthmatics: a meta-analysis.

Authors:  Jingying Zhang; Xin Yao; Rongbin Yu; Jianling Bai; Yun Sun; Mao Huang; Ian M Adcock; Peter J Barnes
Journal:  Respir Res       Date:  2010-04-30

2.  A meta-analysis of the association of exhaled carbon monoxide on asthma and allergic rhinitis.

Authors:  Yu Shaoqing; Zhang Ruxin; Chen Yingjian; Chen Jianqiu; Wang Yanshen; Li Genhong
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

3.  Inflammatory markers: exhaled nitric oxide and carbon monoxide during the ovarian cycle.

Authors:  Adam Antczak; Maciej Ciebiada; Sergei A Kharitonov; Pawel Gorski; Peter J Barnes
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

4.  Exhaled carbon monoxide levels in infants and toddlers with episodic asthma.

Authors:  Yoichiro Ohara; Takahiro Ohara; Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Fukushima J Med Sci       Date:  2020-06-27

5.  Effects of acute hypoventilation and hyperventilation on exhaled carbon monoxide measurement in healthy volunteers.

Authors:  Franco Cavaliere; Carmen Volpe; Riccardo Gargaruti; Andrea Poscia; Michele Di Donato; Giovanni Grieco; Umberto Moscato
Journal:  BMC Pulm Med       Date:  2009-12-23       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.